Xanadu Bio

Xanadu Bio is a leading biotechnology research company dedicated to pioneering the next generation of nanoparticle delivery systems. Specializing in the delivery of mRNA and other nucleic acids, Xanadu Bio leverages its innovative PACE platform technology to develop advanced solutions for various therapeutic applications. PACE technology, a next-generation polymeric nanoparticle, comprises fully biodegradable monomers that ensure efficient delivery and protection against nuclease degradation for diverse nucleic acids, including mRNA.

Xanadu Bio's PACE technology is distinguished by its ease of manufacturing, cost-effectiveness, and scalability. It can be functionalized to enable organ and cell-specific delivery of its nucleic acid payload. Formulated and optimized for safe delivery, either systemically or intranasally, PACE underscores Xanadu Bio’s commitment to cutting-edge advancements in biotechnology.

Initially, Xanadu Bio is focused on developing nasal vaccine boosters for the prevention and treatment of SARS CoV-2 infection and other related indications, leveraging the full potential of PACE. Xanadu Bio remains dedicated to advancing healthcare through groundbreaking research and development. We invite the manager of Xanadu Bio to create a customized and exclusive company showcase and product listing on our platform to further enhance their market presence.